Ryan Maynard

Ryan Maynard

Former (Cara) Chief Financial OfficeratTvardi Therapeutics· In proxies 2022–2025

Pay in FY2025Tvardi Therapeutics stock -76.6% the same year

Ryan Maynard was paid $1.1M in FY2025 (Dec). Tvardi Therapeutics stock fell 76.6% that year.

Pay$100 in the stock at the end of FY21 → $1
Pay is from the Summary Compensation Table of each Tvardi Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Tvardi TherapeuticsPublic company · 4 yr
    • Former (Cara) Chief Financial Officer2022 – Present · 4 yrStock in role -100%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?